BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16361133)

  • 1. Molecular imaging: what can be used today.
    Jager PL; de Korte MA; Lub-de Hooge MN; van Waarde A; Koopmans KP; Perik PJ; de Vries EG
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S27-32. PubMed ID: 16361133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET and PET/CT in pediatric oncology.
    Jadvar H; Connolly LP; Fahey FH; Shulkin BL
    Semin Nucl Med; 2007 Sep; 37(5):316-31. PubMed ID: 17707239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
    J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].
    Han DL; Jiang WR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):1-4. PubMed ID: 19538859
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of cell proliferation: status and prospects.
    Bading JR; Shields AF
    J Nucl Med; 2008 Jun; 49 Suppl 2():64S-80S. PubMed ID: 18523066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging pharmacodynamics in oncology: the potential significance of "flares".
    Trigonis I; Jackson A
    Ann Nucl Med; 2010 Apr; 24(3):137-47. PubMed ID: 20069468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fluorine-18 in radiopharmacy].
    de Beco V; Le Bars D; Scherrmann JM
    Ann Pharm Fr; 2008 Jan; 66(1):60-5. PubMed ID: 18435989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
    Nestle U; Kremp S; Grosu AL
    Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Imaging of biological character of cancer using positron emission tomography(PET)].
    Fukuda H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1281-5. PubMed ID: 18701838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-[18F]FDG PET in clinical oncology.
    Groves AM; Win T; Haim SB; Ell PJ
    Lancet Oncol; 2007 Sep; 8(9):822-30. PubMed ID: 17765191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging using PET for breast cancer.
    Kurihara H; Shimizu C; Miyakita Y; Yoshida M; Hamada A; Kanayama Y; Yonemori K; Hashimoto J; Tani H; Kodaira M; Yunokawa M; Yamamoto H; Watanabe Y; Fujiwara Y; Tamura K
    Breast Cancer; 2016 Jan; 23(1):24-32. PubMed ID: 25917108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational molecular imaging for cancer.
    Pomper MG
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S16-26. PubMed ID: 16361132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorinated tracers for imaging cancer with positron emission tomography.
    Couturier O; Luxen A; Chatal JF; Vuillez JP; Rigo P; Hustinx R
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1182-206. PubMed ID: 15241631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular imaging: new applications for biochemistry.
    Mountz JD; Hsu HC; Wu Q; Liu HG; Zhang HG; Mountz JM
    J Cell Biochem Suppl; 2002; 39():162-71. PubMed ID: 12552616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface to the special issue on quantitative imaging in cancer.
    Yankeelov TE; Gore JC
    Magn Reson Imaging; 2012 Nov; 30(9):1201-2. PubMed ID: 22898684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography].
    Couturier O; Chatal JF; Hustinx R
    Bull Cancer; 2004 Sep; 91(9):695-703. PubMed ID: 15544995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging and 'omic' methods for the molecular diagnosis of cancer.
    Bohndiek SE; Brindle KM
    Expert Rev Mol Diagn; 2010 May; 10(4):417-34. PubMed ID: 20465497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.